| Bioactivity | BACE-IN-1 (Compound 13) is a substituted lmidazo[1 ,2-a]pyridine derivative which can inhibit β-site amyloid precursor protein-cleaving enzyme (BACE) and that may be useful in the treatment of diseases in which BACE is involved, such as Alzheimer's disease. |
| Name | BACE-IN-1 |
| CAS | 1254166-60-3 |
| Formula | C22H16ClN5O2 |
| Molar Mass | 417.85 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Adnan M.M. Mjalli, et al. SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS β-SECRETASE INHIBITORS. WO 2010126745 A1 |
BACE-IN-1
CAS: 1254166-60-3 F: C22H16ClN5O2 W: 417.85
BACE-IN-1 (Compound 13) is a substituted lmidazopyridine derivative which can inhibit β-site amyloid precursor protein-
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.